Dear Editor,
We read with great interest the paper by Jain and Aref [1] entitled "Senile Dementia and Glaucoma: Evidence for a Common Link" published recently in Journal of Ophthalmic and Vision Research. We are grateful to the authors for sharing their valuable review article with the scientific community, and we would appreciate the opportunity to provide an additional viewpoint about a possible common clearance pathway linking Alzheimer's disease (AD) and glaucoma.
Although the potential link between glaucoma and AD is intriguing, the basis for this association remains elusive, despite many years of intensive research. Nevertheless, further elucidation of a common pathophysiological process linking both diseases might offer new perspectives for the development of novel diagnostic and therapeutic strategies for both disorders. As discussed by the authors, [1] our group proposed low intracranial pressure (ICP) occurring in AD as a factor leading to the increased risk of glaucoma. Indeed, the lower ICP reported in AD patients could play a role in the pathogenesis of glaucoma by exerting a higher pressure difference across the lamina cribrosa influencing the physiology and pathophysiology of the optic nerve head, and/or through its association with cerebrospinal fluid (CSF) circulatory failure ultimately resulting in reduced neurotoxin clearance along the optic nerve. [2, 3] The movement of CSF along the outside of the optic nerve is well known. Furthermore, previous studies investigating the flow of fluids in the anterior part of the optic nerve at least suggest some level of exchange between the interstitial fluid (ISF) of the optic nerve and A New Look at Glaucoma the surrounding CSF.
[4] Interestingly, recent insights into the physiology of CSF circulation may shed new light on the link between AD and glaucoma. In particular, Iliff et al [5] have recently proposed the existence of a brain-wide network of paravascular channels, which they termed the 'glymphatic' pathway, along which a large proportion of subarachnoid CSF recirculates through the brain parenchyma, facilitating the clearance of interstitial solutes, including amyloid-β (Aβ), from the brain. One implication is that glymphatic pathway dysfunction may play an important role in the pathogenesis of AD. In light of the key role that the glymphatic pathway may play in the clearance of interstitial solutes and metabolic waste from the brain, this knowledge could be of great importance to our understanding of how solutes are cleared from the ISF in the optic nerve. The observation of such an anatomically distinct clearing system in the optic nerve could provide new insight into the pathogenesis of glaucoma, and introduce a new look at the disease. Indeed, if confirmed, one might expect that a dysfunctional glymphatic system could ultimately result in reduced neurotoxin clearance from the optic nerve and lead to glaucomatous neurodegeneration. [4] Moreover, glymphatic pathway dysfunction as a potential mechanistic link between AD and glaucoma is an attractive hypothesis since this could explain the reported comorbidity of the two disorders. Obviously, further studies are needed to determine whether failure of this clearance system may explain the clinical overlap between AD and glaucoma.
Dear Editor, We appreciate Dr. Wostyn, et al's interest in our manuscript titled, "Senile Dementia and Glaucoma: Evidence for a Common Link".
[1] Dr. Wostyn et al's work in this area is indeed intriguing. Dr. Wostyn et al's hypothesis states that deficient exchange between cerebrospinal fluid and brain interstitial fluid compartments along the optic nerve may allow the accumulation of neurotoxins, including amyloid-β, and subsequently predispose to glaucomatous optic neuropathy. [2] Specifically, this deficiency in waste exchange could occur within a network of diseased paravenous drainage pathways. The glymphatic pathway, as described by Iliff et al, may become dysfunctional due to genetic insult to the Aqp4 gene, which regulates generation of the water channel aquaporin-4 in astrocytes. [3] Animals with deletion of the Aqp4 gene exhibit decreased clearance of amyloid-β via the glymphatic pathway.
Given the potential link between Alzheimer's disease and glaucomatous optic neuropathy, we agree that the aforementioned findings may have important implications regarding the pathophysiology and possible therapy for certain forms of glaucomatous optic neuropathy. It would be interesting to investigate the effects of suppression of the Aqp4 gene on optic nerve health. Possible subsequent glaucomatous optic neuropathy, presumably due to accumulation of amyloid-β via a dysfunctional glymphatic pathway, would strongly support the link between Alzheimer's disease and "normal tension" types of glaucoma. Furthermore, this would offer a potential therapeutic target for both diseases.
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